The cobas® SARS-CoV-2 & Influenza A/B Test is a multiplex reverse transcription polymerase chain reaction (RT-PCR) assay intended for simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A virus, and/or influenza B virus in nasal or nasopharyngeal swab samples.
- Provide accurate diagnosis of SARS-CoV-2 or Influenza A/B infection for proper patient management.
- Offer reliable and affordable testing to reduce further virus spreading after close contact with infected individuals.
- Leverage high-volume cobas® 6800/8800 Systems and broad menu to expand COVID-19 testing solutions.
cobas® SARS-CoV-2 & Influenza A/B is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy cobas® SARS-CoV-2 & Influenza A/B for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring cobas® SARS-CoV-2 & Influenza A/B for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for cobas® SARS-CoV-2 & Influenza A/B or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.